Detalles de la búsqueda
1.
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
Clin Chem
; 70(3): 516-527, 2024 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300881
2.
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Clin Chem
; 69(9): 1050-1061, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477541
3.
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.
Am J Pathol
; 191(4): 618-630, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485866
4.
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab).
Cancer Immunol Immunother
; 70(6): 1781-1788, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33196890
5.
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.
Cancers (Basel)
; 16(3)2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38339235
6.
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
Am J Transl Res
; 16(1): 304-313, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322559
7.
DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma.
Melanoma Res
; 33(2): 116-125, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36735464
8.
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
Clin Epigenetics
; 15(1): 112, 2023 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415208
9.
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.
Oncoimmunology
; 12(1): 2267744, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37868689
10.
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade.
Biomark Res
; 11(1): 56, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259155
11.
CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
J Immunother
; 45(7): 324-334, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35862127
12.
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
Clin Epigenetics
; 14(1): 50, 2022 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35410311
13.
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
Clin Epigenetics
; 13(1): 228, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933671
14.
Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer.
J Immunother
; 44(8): 319-324, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347720
15.
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34446578
16.
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.
Epigenetics
; 15(11): 1195-1212, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32281488
17.
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma.
J Immunother Cancer
; 8(1)2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234847
18.
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
Clin Epigenetics
; 12(1): 94, 2020 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586358
19.
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
EBioMedicine
; 52: 102647, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32028068
20.
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.
EBioMedicine
; 59: 102962, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861198